CJC-1295
CJC-1295, 5mg from $45. GHRH analog without the drug-affinity complex. 99%+ purity by HPLC, third-party COA per lot.
Select Vial Specification:- ISO/IEC 17025 independent lab tested (HPLC & Mass Spectrometry)
- Scannable QR code on every vial linking directly to lot COA
- Complimentary MBP-H2O reconstitution water included
- Same-day tracked dispatch on orders placed before 2:00 PM EST
Research Description
CJC-1295 without DAC is a modified version of GHRH, the hormone that signals growth hormone release. Four amino acids are swapped to slow down enzyme breakdown. It carries no albumin linker. Because it clears quickly, researchers use this version when the timing of a signal is what they are measuring. It also serves as the comparison point against the DAC version.
Modified GRF(1-29), protease-resistant synthetic GHRH(1-29) analog (no albumin-binding DAC)
CJC-1295 (without DAC) is a synthetic analog of GHRH(1-29) with four amino acid substitutions at positions 2, 8, 15, and 27 that confer resistance to DPP-IV and other plasma proteases. It binds and activates GHRH receptors on pituitary somatotrophs with high affinity, mimicking the action of endogenous GHRH.
Storage & Handling Protocol
Store lyophilized vials at −20 °C for long-term stability (up to 24 months) or 2–8 °C for short-term laboratory protocols. Protect from direct light and moisture. Strictly for in-vitro laboratory research use only.
Quality & Lot Specifications
| Compound | CJC-1295 |
| Category | GHRH & Secretagogues |
| Lot Number | MBP-3931 → |
| Purity (RP-HPLC) | ≥ 99.0% (Verified) |
| Identity | Confirmed via ESI-MS |
| Endotoxin Screen | < 0.5 EU/mg (LAL Assay) |
| Physical Form | Lyophilized powder (No fillers) |
| Storage Temp | −20 °C Long-Term |
Customer Reviews
No reviews yet — click '+ Write a Review' to share your experience!